143 related articles for article (PubMed ID: 14565159)
21. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
22. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
Guo M; Roman RJ; Fenstermacher JD; Brown SL; Falck JR; Arbab AS; Edwards PA; Scicli AG
J Pharmacol Exp Ther; 2006 Apr; 317(1):97-108. PubMed ID: 16352703
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
24. Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat.
Zhang X; Jiang F; Kalkanis SN; Yang H; Zhang Z; Katakowski M; Hong X; Zheng X; Chopp M
Photochem Photobiol; 2006; 82(6):1704-11. PubMed ID: 17007560
[TBL] [Abstract][Full Text] [Related]
25. Antivasculature effects of doxorubicin-containing liposomes in an intracranial rat brain tumor model.
Zhou R; Mazurchuk R; Straubinger RM
Cancer Res; 2002 May; 62(9):2561-6. PubMed ID: 11980650
[TBL] [Abstract][Full Text] [Related]
26. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks.
Bouchet A; Lemasson B; Le Duc G; Maisin C; Bräuer-Krisch E; Siegbahn EA; Renaud L; Khalil E; Rémy C; Poillot C; Bravin A; Laissue JA; Barbier EL; Serduc R
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1503-12. PubMed ID: 20932689
[TBL] [Abstract][Full Text] [Related]
27. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG
AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenesis enhances intratumoral drug retention.
Ma J; Chen CS; Blute T; Waxman DJ
Cancer Res; 2011 Apr; 71(7):2675-85. PubMed ID: 21447737
[TBL] [Abstract][Full Text] [Related]
30. Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model.
Yoshida D; Ikeda Y; Nakazawa S
Neurosurgery; 1995 Aug; 37(2):287-92; discussion 292-3. PubMed ID: 7477781
[TBL] [Abstract][Full Text] [Related]
31. MRI measurement of change in vascular parameters in the 9L rat cerebral tumor after dexamethasone administration.
Ewing JR; Brown SL; Nagaraja TN; Bagher-Ebadian H; Paudyal R; Panda S; Knight RA; Ding G; Jiang Q; Lu M; Fenstermacher JD
J Magn Reson Imaging; 2008 Jun; 27(6):1430-8. PubMed ID: 18504732
[TBL] [Abstract][Full Text] [Related]
32. Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2-μMRA.
Lin CY; Siow TY; Lin MH; Hsu YH; Tung YY; Jang T; Recht L; Chang C
Angiogenesis; 2013 Oct; 16(4):785-93. PubMed ID: 23736837
[TBL] [Abstract][Full Text] [Related]
33. Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study.
Bogdanov A; Marecos E; Cheng HC; Chandrasekaran L; Krutzsch HC; Roberts DD; Weissleder R
Neoplasia; 1999 Nov; 1(5):438-45. PubMed ID: 10933059
[TBL] [Abstract][Full Text] [Related]
34. Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model.
Nagaraja TN; Elmghirbi R; Brown SL; Schultz LR; Lee IY; Keenan KA; Panda S; Cabral G; Mikkelsen T; Ewing JR
Magn Reson Imaging; 2017 Dec; 44():131-139. PubMed ID: 28887206
[TBL] [Abstract][Full Text] [Related]
35. Characterization of glioma microcirculation and tissue features using intravoxel incoherent motion magnetic resonance imaging in a rat brain model.
Iima M; Reynaud O; Tsurugizawa T; Ciobanu L; Li JR; Geffroy F; Djemai B; Umehana M; Le Bihan D
Invest Radiol; 2014 Jul; 49(7):485-90. PubMed ID: 24619211
[TBL] [Abstract][Full Text] [Related]
36. Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies.
Pohlmann A; Karczewski P; Ku MC; Dieringer B; Waiczies H; Wisbrun N; Kox S; Palatnik I; Reimann HM; Eichhorn C; Waiczies S; Hempel P; Lemke B; Niendorf T; Bimmler M
NMR Biomed; 2014 Sep; 27(9):1085-93. PubMed ID: 25060359
[TBL] [Abstract][Full Text] [Related]
37. The role of minocycline in the treatment of intracranial 9L glioma.
Weingart JD; Sipos EP; Brem H
J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
[TBL] [Abstract][Full Text] [Related]
38. Liposome-mediated therapy of intracranial brain tumors in a rat model.
Sharma US; Sharma A; Chau RI; Straubinger RM
Pharm Res; 1997 Aug; 14(8):992-8. PubMed ID: 9279878
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.
Pishko GL; Muldoon LL; Pagel MA; Schwartz DL; Neuwelt EA
Fluids Barriers CNS; 2015 Feb; 12():5. PubMed ID: 25879723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
